Interested in licensing this patent?

MTEC can help explore whether this patent might be available for licensing for your application.

Publication Number

US-12766275-B2

Patent

Publication Date

2026-10-20

Expiration Date


Abstract

Methods of making components for a medicinal delivery device are described, in which a base composition comprising a polysulphone is applied to the surface of a component to create a base layer, a primer composition comprising a silane having two or more reactive silane groups separated by an organic linker group is applied to the base layer to create primed surface, and a coating composition comprising an at least partially fluorinated compound is applied to the primed surface. Corresponding coated components and a medicinal delivery device are disclosed.

Core Innovation

The invention describes a coated component for a medicinal delivery device, with a polysulphone base layer between the component and a fluorine-containing coating. The fluorine-containing coating has a polyfluoropolyether-containing layer and a non-fluorinated layer that share at least one covalent bond; the non-fluorinated layer is bonded to the base layer.

The disclosed coating is intended to reduce medicament deposition on device components and improve dose consistency. The document reports that polyfluoropolyether coatings with 20–40 repeating units improve valve lubricity and reduce actuation force. It also describes lower salbutamol sulphate deposition on coated aluminium canisters than on uncoated canisters, including with a polyethersulphone-based coating across tested humidity conditions.

Claims Coverage

The supplied relevant claims identify one independent claim, which covers a coated component for a medicinal delivery device.

Coated medicinal delivery device component

A component has a polysulphone base layer intermediate the component and a fluorine-containing coating. The coating comprises a polyfluoropolyether-containing layer with polyfluoropolyether silane entities and a non-fluorinated layer with Formula IIb entities; the two layers share at least one covalent bond, and the non-fluorinated layer is bonded to the base layer.

The independent claim centers on the layered coating structure: a polysulphone base layer and a fluorine-containing coating comprising covalently linked polyfluoropolyether-containing and non-fluorinated layers.

Stated Advantages

The coating is intended to reduce medicament deposition and improve dose consistency.

Polyfluoropolyether coatings with 20–40 repeating units are reported to improve valve lubricity and reduce actuation force.

The document reports substantially lower salbutamol sulphate deposition on coated aluminium canisters than on uncoated canisters. The polyethersulphone-based coating shows 1–5% deposition across tested humidity conditions.

Documented Applications

Coated components for medicinal delivery devices, including actuators, aerosol containers, ferrules, valve bodies, valve stems, and compression springs.

Use in metered-dose inhalers and other medicinal delivery devices.

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.